Finzati - Logo
BLRX logo

BioLineRx Ltd.

BLRXBiotechnology
$2.67
-0.02 (-0.74%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$12.01M
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 96.8%Manageable debt level · 0.56Healthy liquidity · 1.95Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Sep 2, 2026, 12:15 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$2.67
Change-0.74%
Market Cap$12.01M
52W Range2.15 - 4.56
Beta0.71
Gross Margin36.19%
Oper. Margin-8.72%
Profit Margin-99.58%
Debt/Eq0.56
Current Ratio1.95
Quick Ratio1.78
Volume69.25K

Investment DNA

How strong this company looks for long-term investors

49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
73/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
59/100
Why this score
Positive revenue growth · 96.8%Manageable debt level · 0.56Healthy liquidity · 1.95Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 7/27/2011
Industry: Biotechnology
P/B i: 0.63
Debt / Equity i: 0.56
Operating Margin: -871.78%
Net Margin: -99.58%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.56
Current Ratio: 1.95
Quick Ratio: 1.78
Status: Good

Insider Transactions

Recent executive and insider activity

Yan Shaoyu
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
04/10/2026
Type
OTHER
Molcho Avraham
Transaction: 01/01/2025
OTHER
Change
+2,055,000
Price
$0.05
Filing
03/31/2026
Type
OTHER
Dar Rami
Transaction: 01/01/2025
OTHER
Change
+2,055,000
Price
$0.05
Filing
03/31/2026
Type
OTHER